As a result, C‐Met‐CAR‐NK cells incorporating DAP10 as a beneficial activator for NK cell stimulation were created, it has been shown that this CAR cells by targeting C‐met is a promising strategy for the treatment of c‐Met‐positive cancers [182]. The gene discussed is MET; the disease is cancer.